MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians for skin cancer detection, today announced the publication of ...

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

Credit: DermaSensor. The device assists primary care providers in assessing skin lesions suggestive of melanoma, basal cell carcinoma, and/or squamous cell carcinoma in patients aged 40 years and ...

A shoebox-sized optical device reads glucose directly through the skin in seconds, offering a promising step toward truly noninvasive, point-of-care glucose monitoring. Pipeline for the development of ...

A study that looks into the potential of future wearables to non-invasively measure blood glucose has brought promising results. Nature published the study, which involved the participation of 50 ...

The DLP4500NIR is the first DLP device optimized for use with near infrared (NIR) light. Together, the DLP4500NIR and the DLP NIRscan evaluation module suit transmittance and reflective spectroscopy ...

Data published in the Journal of the American Board of Family Medicine shows that DermaSensor’s elastic scattering spectroscopy device improves primary care clinicians’ ability to assess skin lesions ...